ERBB2 and breast carcinoma: Among women, breast cancer remainsthe most frequently diagnosed malignancy. The overexpression of human epidermal growth factor receptor 2 (HER2),an oncogene that regulates cell growth and differentiation, is observed in approximately 20–25% ofbreast cancer cases and is associated with aggressive disease progression.